Financial Sense Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Hold
1,612
0.3% 57
2025
Q4
$1.73M Buy
1,612
+18
+1% +$17.2K 0.32% 59
2025
Q3
$1.22M Sell
1,594
-48
-3% -$35.7K 0.21% 71
2025
Q2
$1.28M Sell
1,642
-40
-2% -$31.1K 0.3% 58
2025
Q1
$1.39M Hold
1,682
0.39% 47
2024
Q4
$1.3M Sell
1,682
-241
-13% -$200K 0.43% 46
2024
Q3
$1.7M Sell
1,923
-1,361
-41% -$1.22M 0.46% 41
2024
Q2
$2.97M Buy
3,284
+40
+1% +$32K 0.91% 29
2024
Q1
$2.52M Buy
3,244
+28
+0.9% +$19.9K 0.83% 34
2023
Q4
$1.87M Buy
3,216
+29
+0.9% +$16.9K 0.7% 38
2023
Q3
$1.71M Hold
3,187
0.73% 39
2023
Q2
$1.49M Hold
3,187
0.63% 49
2023
Q1
$1.09M Sell
3,187
-722
-18% -$244K 0.48% 56
2022
Q4
$1.43M Buy
+3,909
New +$1.39M 0.59% 47

Other funds holding LLY

Financial Sense Advisors's LLY Position: Q1 2026 in Review

Financial Sense Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 1,612 shares worth $1.48M. The position accounts for 0.3% of the portfolio, ranked #57.

Financial Sense Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.97M in Q2 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Financial Sense Advisors held 1,612 shares of Eli Lilly worth $1.48M as of Q1 2026.
  • Financial Sense Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.3% of Financial Sense Advisors's portfolio in Q1 2026, its #57 holding.
  • Financial Sense Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Financial Sense Advisors's Eli Lilly position peaked at $2.97M in Q2 2024.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Financial Sense Advisors's 13F filing for Q1 2026, filed 14 May 2026.